Report Detail

Other Global Prostate Specific Antigen (PSA) Testing Market Opportunities and Forecast 2022-2028

  • RnM4419080
  • |
  • 04 April, 2022
  • |
  • Global
  • |
  • 133 Pages
  • |
  • GRD Survey
  • |
  • Other

This report provides a comprehensive analysis of current global Prostate Specific Antigen (PSA) Testing market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Prostate Specific Antigen (PSA) Testing industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to GRD Survey, the global Prostate Specific Antigen (PSA) Testing market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Prostate Specific Antigen (PSA) Testing Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Prostate Specific Antigen (PSA) Testing market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Prostate Specific Antigen (PSA) Testing Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Prostate Specific Antigen (PSA) Testing industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Radioimmunoassay
Enzyme Immunoassay

Segmented by Application
Hospitals
Clinics
Diagnostic Centers
Research Institute
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Siemens Healthineers
Roche Holding AG
Ortho Clinical
Merck
Mediwatch(LABORIE)
GlaxoSmith Kline
GE Healthcare
Fujirebio
Endocare
DiaSorin
Cleveland Diagnostics
Bristol Myers Squibb
Boditech
Beckman Coulter
Anixa Biosciences
Abbott


Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Prostate Specific Antigen (PSA) Testing Market Status and Forecast (2017-2028)
      • 1.3.2 Global Prostate Specific Antigen (PSA) Testing Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Prostate Specific Antigen (PSA) Testing Supply by Company

    • 2.1 Global Prostate Specific Antigen (PSA) Testing Sales Value by Company
    • 2.2 Prostate Specific Antigen (PSA) Testing Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Prostate Specific Antigen (PSA) Testing Market Status by Type

    • 3.1 Prostate Specific Antigen (PSA) Testing Type Introduction
      • 3.1.1 Radioimmunoassay
      • 3.1.2 Enzyme Immunoassay
    • 3.2 Global Prostate Specific Antigen (PSA) Testing Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Prostate Specific Antigen (PSA) Testing Market Status by Application

    • 4.1 Prostate Specific Antigen (PSA) Testing Segment by Application
      • 4.1.1 Hospitals
      • 4.1.2 Clinics
      • 4.1.3 Diagnostic Centers
      • 4.1.4 Research Institute
      • 4.1.5 Others
    • 4.2 Global Prostate Specific Antigen (PSA) Testing Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Prostate Specific Antigen (PSA) Testing Market Status by Region

    • 5.1 Global Prostate Specific Antigen (PSA) Testing Market by Region
    • 5.2 North America Prostate Specific Antigen (PSA) Testing Market Status
    • 5.3 Europe Prostate Specific Antigen (PSA) Testing Market Status
    • 5.4 Asia Pacific Prostate Specific Antigen (PSA) Testing Market Status
    • 5.5 Central & South America Prostate Specific Antigen (PSA) Testing Market Status
    • 5.6 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Status

    6 North America Prostate Specific Antigen (PSA) Testing Market Status

    • 6.1 North America Prostate Specific Antigen (PSA) Testing Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Prostate Specific Antigen (PSA) Testing Market Status

    • 7.1 Europe Prostate Specific Antigen (PSA) Testing Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Prostate Specific Antigen (PSA) Testing Market Status

    • 8.1 Asia Pacific Prostate Specific Antigen (PSA) Testing Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Prostate Specific Antigen (PSA) Testing Market Status

    • 9.1 Central & South America Prostate Specific Antigen (PSA) Testing Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Status

    • 10.1 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Prostate Specific Antigen (PSA) Testing Market Forecast by Type and by Application

    • 12.1 Global Prostate Specific Antigen (PSA) Testing Sales Value Forecast (2023-2028)
    • 12.2 Global Prostate Specific Antigen (PSA) Testing Forecast by Type
    • 12.3 Global Prostate Specific Antigen (PSA) Testing Forecast by Application

    13 Global Prostate Specific Antigen (PSA) Testing Market Forecast by Region/Country

    • 13.1 Global Prostate Specific Antigen (PSA) Testing Market Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Siemens Healthineers
      • 14.1.1 Company Information
      • 14.1.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.1.3 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Roche Holding AG
      • 14.2.1 Company Information
      • 14.2.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.2.3 Roche Holding AG Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Ortho Clinical
      • 14.3.1 Company Information
      • 14.3.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.3.3 Ortho Clinical Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Merck
      • 14.4.1 Company Information
      • 14.4.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.4.3 Merck Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Mediwatch(LABORIE)
      • 14.5.1 Company Information
      • 14.5.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.5.3 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 GlaxoSmith Kline
      • 14.6.1 Company Information
      • 14.6.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.6.3 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 GE Healthcare
      • 14.7.1 Company Information
      • 14.7.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.7.3 GE Healthcare Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Fujirebio
      • 14.8.1 Company Information
      • 14.8.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.8.3 Fujirebio Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Endocare
      • 14.9.1 Company Information
      • 14.9.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.9.3 Endocare Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 DiaSorin
      • 14.10.1 Company Information
      • 14.10.2 Prostate Specific Antigen (PSA) Testing Product Introduction
      • 14.10.3 DiaSorin Prostate Specific Antigen (PSA) Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 Cleveland Diagnostics
    • 14.12 Bristol Myers Squibb
    • 14.13 Boditech
    • 14.14 Beckman Coulter
    • 14.15 Anixa Biosciences
    • 14.16 Abbott

    15 Conclusion

      16 Methodology

      Summary:
      Get latest Market Research Reports on Prostate Specific Antigen (PSA) Testing. Industry analysis & Market Report on Prostate Specific Antigen (PSA) Testing is a syndicated market report, published as Global Prostate Specific Antigen (PSA) Testing Market Opportunities and Forecast 2022-2028. It is complete Research Study and Industry Analysis of Prostate Specific Antigen (PSA) Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,980.00
      $4,470.00
      $5,960.00
      2,375.06
      3,562.59
      4,750.12
      2,771.40
      4,157.10
      5,542.80
      455,582.40
      683,373.60
      911,164.80
      248,621.40
      372,932.10
      497,242.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report